Relative bioavailability study of marketed and lower dose ambrisentan in healthy adult participants
An open-label, randomized three period cross-over relative bioavailability study to compare the pharmacokinetic parameters of a lower dose formulation of ambrisentan (GSK1325760) with marketed ambrisentan in healthy adult participants An open-label, randomized three period cross-over relative bioavailability study to compare the phar ...